Barclays’s AllianzIM U.S. Equity Buffer10 Nov ETF NVBT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.85K Buy
+72
New +$2.78K ﹤0.01% 4835
2025
Q4
– Sell
-4,829
Closed -$175K – 5545
2025
Q3
$175K Sell
4,829
-686
-12% -$24.2K ﹤0.01% 4393
2025
Q2
$189K Buy
5,515
+993
+22% +$32.2K ﹤0.01% 4319
2025
Q1
$144K Buy
+4,522
New +$148K ﹤0.01% 4245

Other funds holding NVBT

Barclays's NVBT Position: Q2 2026 in Review

Barclays opened a new position in AllianzIM U.S. Equity Buffer10 Nov ETF (NVBT) in Q2 2026: 72 shares worth $2.85K. The stake represents ﹤0.01% of the portfolio and ranks #4835 among its holdings. This is a return to the name: Barclays previously reported a position in NVBT as recently as Q3 2025.

Barclays first reported a position in NVBT in Q1 2025 and has held it in 4 quarters since. The position peaked at $189K in Q2 2025. 26 funds tracked by Wall St. Rank hold NVBT as of Q2 2026.

  • Barclays held 72 shares of AllianzIM U.S. Equity Buffer10 Nov ETF worth $2.85K as of Q2 2026.
  • AllianzIM U.S. Equity Buffer10 Nov ETF was a new Barclays position in Q2 2026.
  • AllianzIM U.S. Equity Buffer10 Nov ETF made up ﹤0.01% of Barclays's portfolio in Q2 2026, its #4835 holding.
  • Barclays first reported a position in AllianzIM U.S. Equity Buffer10 Nov ETF in Q1 2025 and has held it in 4 quarters since.
  • Barclays's AllianzIM U.S. Equity Buffer10 Nov ETF position peaked at $189K in Q2 2025.
  • 26 funds tracked by Wall St. Rank held AllianzIM U.S. Equity Buffer10 Nov ETF as of Q2 2026.

Based on Barclays's 13F filing for Q2 2026, filed 14 Aug 2026.